U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
MOROCTOCOG ALFA
113E3Z3CJJ
US Approved Rx (2007)
First approved in 2003
General
Record Details
Variant Concepts
1
Names
10
Classification
2
Identifiers
12
Subunits
2
Disulfide Links
7
Glycosylation
6
Relationships
1
Active Moiety
1
Characteristic Attributes
2
MOROCTOCOG ALFA
113E3Z3CJJ
US Approved Rx (2007)
First approved in 2003
General
Approval Year
2003
176
Record Details
Substance Class
Protein
Protein Sub Type
Sequence Type
COMPLETE
Record UNII
113E3Z3CJJ
Record Status
Validated (UNII)
Record Version
13
12
11
10
9
8
7
6
5
4
3
2
1
Show
5
20
100
All
entries
Related Record
Type
Related Record
Type
No data available in table
Showing 0 to 0 of 0 entries
Previous
Next
Names
10
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
MOROCTOCOG ALFA
Official Name
English
ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT RESIDUES 743-1636 DELETED
Preferred Name
English
MOROCTOCOG ALFA [MI]
Common Name
English
Moroctocog alfa [WHO-DD]
Common Name
English
MOROCTOCOG ALFA [MART.]
Common Name
English
Showing 1 to 5 of 10 entries
Previous
1
2
Next
Classification
2
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
COAGULATION PROTEIN DISORERS
EMA EPAR
DISEASES
BLOOD AND LYMPHATIC DISEASES
HEMATOLOGIC DISEASES
BLOOD COAGULATION DISORDERS
COAGULATION PROTEIN DISORERS
HEMOPHILIA A
EMA ASSESSMENT REPORTS
REFACTO AF (AUTHORIZED: HEMOPHILIA A)
Agent Affecting Blood or Body Fluid
Pharmacologic Substance
[C1909]
Agent Affecting Blood or Body Fluid
[C78275]
Hemostatic Agent
NCI_THESAURUS
C78311
Showing 1 to 2 of 2 entries
Previous
1
Next
Identifiers
12
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
EVMPD
SUB16445MIG
PRIMARY
RXCUI
1300485
PRIMARY
RxNorm
DRUG BANK
DB13999
PRIMARY
FDA UNII
113E3Z3CJJ
PRIMARY
ChEMBL
CHEMBL2109137
PRIMARY
Showing 1 to 5 of 12 entries
Previous
1
2
3
Next
Subunits
2
Disulfide Links
7
Show
5
20
100
All
entries
From
To
From
To
1_153
1_179
1_248
1_329
1_528
1_554
1_630
1_711
2_251
2_255
Showing 1 to 5 of 7 entries
Previous
1
2
Next
Glycosylation
6
Glycosylation Type
MAMMALIAN
Show
5
20
100
All
entries
Glycosylation Link Type
Site
Glycosylation Link Type
Site
N
1_37
N
1_41
N
1_239
N
1_582
N
2_162
Showing 1 to 5 of 6 entries
Previous
1
2
Next
Relationships
1
Show
5
20
100
All
entries
Related Record
Type
Details
Related Record
Type
Details
ANTIHEMOPHILIC FACTOR (RECOMBINANT, B-DOMAIN DELETED), PLASMA/ALBUMIN FREE
SUB_CONCEPT->SUBSTANCE
Showing 1 to 1 of 1 entries
Previous
1
Next
Active Moiety
1
Show
5
20
100
All
entries
Related Record
Type
Details
Related Record
Type
Details
113E3Z3CJJ
MOROCTOCOG ALFA
ACTIVE MOIETY
Showing 1 to 1 of 1 entries
Previous
1
Next
Characteristic Attributes
2
Show
5
20
100
All
entries
Name
Property Type
Amount
Referenced Substance
Defining
Parameters
References
Name
Property Type
Amount
Referenced Substance
Defining
Parameters
References
Molecular Formula
CHEMICAL
ESTIMATED
C7448H11285N1985O2166S62
MOL_WEIGHT:NUMBER(CALCULATED)
CHEMICAL
ESTIMATED 227000 Da (average)
Showing 1 to 2 of 2 entries
Previous
1
Next
